ORBIMED ADVISORS LLC
CIK 0001055951Director10% Owner
Filings
5
Latest Feb 14, 2024
Issuers covered
5
Showing
5 of 5
Page 1
Issuers
Companies where ORBIMED ADVISORS LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALPN | ALPINE IMMUNE SCIENCES, INC. | 1 | Jan 16, 2024 |
| ACET | Adicet Bio, Inc. | 1 | Jan 26, 2024 |
| AVBP | ArriVent Biopharma, Inc. | 1 | Jan 31, 2024 |
| EWTX | Edgewise Therapeutics, Inc. | 1 | Jan 25, 2024 |
| THRX | Theseus Pharmaceuticals, Inc. | 1 | Feb 14, 2024 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Issuer | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 14, 2024 | THRXTheseus Pharmaceuticals, Inc. | U | 17,063,000 | — | — | |
| Jan 31, 2024 | AVBPArriVent Biopharma, Inc. | P | 222,222 | $18.00 | $3,999,996 | |
| Jan 26, 2024 | ACETAdicet Bio, Inc. | P | 1,841,100 | $2.40 | $4,418,640 | |
| Jan 25, 2024 | EWTXEdgewise Therapeutics, Inc. | P | 454,545 | $11.00 | $4,999,995 | |
| Jan 16, 2024 | ALPNALPINE IMMUNE SCIENCES, INC. | X | 145,251 | $12.74 | $1,850,498 |
Showing 1–5 of 5
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.